Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis

被引：0
|
作者：
Gong, Inna [1 ]
Crump, Michael [1 ]
Prica, Anca [1 ]
Calzavara, Andrew [2 ]
Liu, Ning [3 ]
Rodin, Danielle [4 ]
Hodgson, David [5 ]
Mozessohn, Lee [6 ]
Cheung, Matthew C. [6 ]
Kuruvilla, John [7 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[2] Inst Clin Evaluat Sci ICES, Toronto, ON, Canada
[3] ICES, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[7] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3092 / 3093
页数：2
相关论文
共 50 条
  • [1] Therapies and Outcomes for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Contemporary, Nationwide, Population-Based Study in the Netherlands
    Pennings, Elise R. A.
    Durmaz, Mujde
    Visser, Otto
    Posthuma, Eduardus F. M.
    Issa, Djamila E.
    Chamuleau, Martine E. D.
    Lugtenburg, Pieternella
    Kersten, Marie Jose
    Dinmohamed, Avinash G.
    BLOOD, 2022, 140 : 9564 - 9565
  • [2] Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands
    Elise R. A. Pennings
    Müjde Durmaz
    Otto Visser
    Eduardus F. M. Posthuma
    Djamila E. Issa
    Martine E. D. Chamuleau
    Pieternella J. Lugtenburg
    Marie José Kersten
    Avinash G. Dinmohamed
    Blood Cancer Journal, 14
  • [3] Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands
    Pennings, Elise R. A.
    Durmaz, Mujde
    Visser, Otto
    Posthuma, Eduardus F. M.
    Issa, Djamila E.
    Chamuleau, Martine E. D.
    Lugtenburg, Pieternella J.
    Kersten, Marie Jose
    Dinmohamed, Avinash G.
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [4] A Prognostic Nomogram and Survival Analysis in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
    Jiang, Shiyu
    Qin, Yan
    Liu, Peng
    Yang, Jiangliang
    Yang, Sheng
    He, Xiaohui
    Zhou, Shengyu
    Gui, Lin
    Zhang, Changgong
    Zhou, Liqiang
    Han, Ming-Zhe
    Sun, Yan
    Shi, Yuankai
    BLOOD, 2018, 132
  • [5] Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study
    Arboe, Bente
    Olsen, Maja Halgren
    Gorlov, Jette Sonderskov
    Duun-Henriksen, Anne Katrine
    Dalton, Susanne Oksbjerg
    Johansen, Christoffer
    Brown, Peter de Nully
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 207 - 216
  • [6] Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma
    Desai, Sanjal H.
    Mwangi, Raphael
    Smith, Alexandra N.
    Maurer, Matthew J.
    Farooq, Umar
    King, Rebecca L.
    Cerhan, James R.
    Feldman, Andrew L.
    Habermann, Thomas M.
    Thompson, Carrie A.
    Wang, Yucai
    Ansell, Stephen M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (01) : 39 - 49
  • [7] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [8] Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
    Van Dijck, Ruben
    Janssens, Ann
    Dierickx, Daan
    Delforge, Michel
    Gheysens, Olivier
    Tousseyn, Thomas
    Verhoef, Gregor
    ANNALS OF HEMATOLOGY, 2017, 96 (10) : 1759 - 1762
  • [9] Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
    Ruben Van Dijck
    Ann Janssens
    Daan Dierickx
    Michel Delforge
    Olivier Gheysens
    Thomas Tousseyn
    Gregor Verhoef
    Annals of Hematology, 2017, 96 : 1759 - 1762
  • [10] Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Jerkeman, Mats
    Hasselblom, Sverker
    Wahlin, Bjorn E.
    Andersson, Per-Ola
    Smedby, Karin E.
    BLOOD, 2018, 132
12345